Further defines the obligations for our United States employee in four key areas: Employment Practices, Business Conduct @Philips, Internal and External Controls and Reporting, and Sustainability sets the worldwide standard for always acting with integrity and sets forth our commitment to always act with integrity towards our customers, employees, business partners, and shareholders, as well as the wider community in which we operate.
Establishes specific guidelines for our interactions with U.S. Healthcare providers and professionals.
Document provides an overview of our Legal Compliance Program and our commitment to operating within the applicable laws, regulations, guidelines, and policies.
The North America Compliance Guidance
The CMS open payments website provides information about Philips NA LLC’s financial relationships with healthcare providers, as well as providers’ relationships with other companies. All United States Transparency Laws require Medical Device Manufacturers to report all Transfers of Value provided (directly or indirectly) to any Covered Recipient. Industry submits these Transfers of Value, annually, to the Centers for Medicare & Medicaid Services (CMS).
Philips abides by local laws in countries around the world on employment policy. As of April 1, 2025, all former Philips policies and documents concerning DEI initiatives in the United States are amended to adhere to U.S. Executive Orders relating to DEI issued in January 2025. Any document, content or policy created previous to this date is superseded and replaced.
Notice
Philips North America LLC, a division of Royal Philips, and its affiliates (“Philips”), has established and is operating under a Comprehensive Compliance Program (“CCP”). Where applicable, is in accordance with the “Compliance Program Guidance for Pharmaceutical Manufacturers” issued by the United States Department of Health and Human Services Office of Inspector General (“CPG”), and the AdvaMed and NEMA/MITA Codes of Ethics on Interactions with Healthcare Providers (“Device Industry Codes”).
Not a drug manufacturer
Because Philips is a medical device manufacturer—not a drug manufacturer—certain guidance set forth in the CPG does not apply to Philips and its operations. Similarly, Philips’s CCP is based on Device Industry Codes and not the PhRMA Code of Ethics for the pharmaceutical industry. With these clarifications and Philips’s good faith understanding of the statutory requirements, Philips is —to the best of its knowledge—in compliance with the provisions of the California Health and Safety Code §§119400 – 119402, to the extent they apply to Philips North America LLC. [Updated 01-01-2024]
Compliance updated
Please note that our Philips compliance program may vary from country to country to reflect the legal differences, and not all programs are available for posting.